| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-069188 |
| cik | 1641281 |
| name | BOLT BIOTHERAPEUTICS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | CA |
| cityba | REDWOOD CITY |
| zipba | 94063 |
| bas1 | 900 CHESAPEAKE DRIVE |
| bas2 | |
| baph | 650-665-9295 |
| countryma | US |
| stprma | CA |
| cityma | REDWOOD CITY |
| zipma | 94063 |
| mas1 | 900 CHESAPEAKE DRIVE |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 472804636 |
| former | BOLT THERAPEUTICS, INC. |
| changed | 20150504 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250512 |
| accepted | 2025-05-12 16:08:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | bolt-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069188 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 97000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Additional Paid In Capital Common Stock | 484504000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Accrued Expenses And Other Current Liabilities | 6545000.0000 | USD | 0 | 0000950170-25-069188 | |||
| 0000950170-25-069188 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 40000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 709000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Common Stock Shares Issued | 38339697.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Gain Loss On Sale Of Property Plant Equipment | 288000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Liabilities | 39052000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Long Term Investments | 22880000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 615000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Other Income | 22000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Payments To Acquire Marketable Securities | 992000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 14580000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Profit Loss | -10811000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Restricted Cash Noncurrent | 981000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Restricted Cash Noncurrent | 1600000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Chesapeake Master Lease; | ||
| 0000950170-25-069188 | 20240331 | Share Based Compensation | 2302000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Shares Outstanding | 38339697.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069188 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 38068424.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Assets Current | 42509000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Cash And Cash Equivalents At Carrying Value | 7205000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 12575000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Earnings Per Share Basic | -0.2900 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Gain Loss On Sale Of Property Plant Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -3544000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Increase Decrease In Deferred Revenue | -503000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Liabilities | 42434000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Liabilities And Stockholders Equity | 99632000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Liabilities And Stockholders Equity | 85862000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Net Cash Provided By Used In Operating Activities | -16751000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Operating Income Loss | -17092000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Operating Income Loss | -12115000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Operating Lease Liability Noncurrent | 22958000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Operating Lease Right Of Use Asset | 21756000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 773000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -73000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20240331 | Other Income | 4675000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 33261000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Profit Loss | -11040000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Property Plant And Equipment Net | 2065000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Retained Earnings Accumulated Deficit | -427403000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Revenues | 1200000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Genmab Agreement; | ||
| 0000950170-25-069188 | 20250331 | Revenues | 1200000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Genmab Agreement; | ||
| 0000950170-25-069188 | 20231231 | Stockholders Equity | 112741000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Stockholders Equity | 46810000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Deferred Revenue Noncurrent | 3620000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Depreciation Depletion And Amortization | 458000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Increase Decrease In Deferred Revenue | -4071000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 169000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Investment Income Net | 1053000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Liabilities Current | 13562000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Net Cash Provided By Used In Investing Activities | 10203000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Net Income Loss | -10811000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Operating Lease Liability Noncurrent | 22309000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Other Assets Noncurrent | 62000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Accounts Payable Current | 1507000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Additional Paid In Capital Common Stock | 485213000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -57000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 963000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Restricted Cash Current | 784000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Retained Earnings Accumulated Deficit | -438443000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Revenues | 1222000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20231231 | Stockholders Equity | 37000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20231231 | Stockholders Equity | -364284000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20241231 | Stockholders Equity | 97000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20241231 | Stockholders Equity | -427403000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20250331 | Stockholders Equity | 40000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20250331 | Stockholders Equity | -438443000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20240331 | Net Income Loss | -10811000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20250331 | Net Income Loss | -11040000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Nonoperating Income Expense | 1075000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Accrued Expenses And Other Current Liabilities | 9083000.0000 | USD | 0 | 0000950170-25-069188 | |||
| 0000950170-25-069188 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2302000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Assets | 85862000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10156000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069188 | 20241231 | Common Stock Shares Outstanding | 38339697.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Earnings Per Share Basic | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | General And Administrative Expense | 5837000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | -43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Other Assets Noncurrent | 51000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -57000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20240331 | Payments To Acquire Marketable Securities | 23058000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Research And Development Expense | 9512000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Share Based Compensation | 709000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20231231 | Shares Outstanding | 38114606.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069188 | 20240331 | Stockholders Equity | -36000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-069188 | 20240331 | Stockholders Equity | -375095000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20250331 | Stockholders Equity | 485213000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 709000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20250331 | Cash And Cash Equivalents At Carrying Value | 8391000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 1186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Comprehensive Income Net Of Tax | -10884000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Deferred Revenue Current | 3015000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -2511000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -73000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Restricted Cash And Cash Equivalents At Carrying Value | 1765000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Short Term Investments | 40118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Short Term Investments | 30447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20231231 | Stockholders Equity | 476988000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20240331 | Stockholders Equity | 104159000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Stockholders Equity | 479290000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 38339697.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069188 | 20241231 | Assets | 99632000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Deferred Revenue Current | 3083000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Depreciation Depletion And Amortization | 399000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | General And Administrative Expense | 3825000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Increase Decrease In Operating Lease Liabilities | -652000.0000 | USD | 1 | 0000950170-25-069188 | |||
| 0000950170-25-069188 | 20241231 | Liabilities Current | 15856000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Nonoperating Income Expense | 6281000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Operating Expenses | 22366000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Operating Lease Liability Current | 2251000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Other Liabilities Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Other Liabilities Noncurrent | 132000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Prepaid Expense And Other Assets Current | 2707000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Prepaid Expense And Other Assets Current | 2887000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Restricted Cash Current | 784000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Restricted Cash Noncurrent | 981000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Stockholders Equity | 57198000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Vesting Of Restricted Stock Units | 13134.0000 | shares | 1 | 0000950170-25-069188 | Equity Components= Common Stock; | ||
| 0000950170-25-069188 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 38068424.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Common Stock Shares Outstanding | 38339697.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Comprehensive Income Net Of Tax | -11097000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Deferred Revenue Noncurrent | 3049000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 8970000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Accounts Payable Current | 1534000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2302000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20241231 | Assets Current | 50814000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 6027000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6027000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Investment Income Net | 1606000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Net Income Loss | -11040000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069188 | 20250331 | Operating Lease Liability Current | 2400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Operating Lease Right Of Use Asset | 21141000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 1000000.0000 | USD | 1 | us-gaap/2024 | Property Plant And Equipment By Type= Laboratory Equipment; | ||
| 0000950170-25-069188 | 20240331 | Restricted Cash And Cash Equivalents At Carrying Value | 1765000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Revenues | 5274000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Shares Outstanding | 38127740.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069188 | 20241231 | Stockholders Equity | 484504000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069188 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 38339697.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 1033000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 209000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Cash And Cash Equivalents At Carrying Value | 4262000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 10156000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -6548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Common Stock Shares Issued | 38339697.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Earnings Per Share Diluted | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Earnings Per Share Diluted | -0.2900 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Increase Decrease In Operating Lease Liabilities | -500000.0000 | USD | 1 | 0000950170-25-069188 | |||
| 0000950170-25-069188 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | 132000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Long Term Investments | 19115000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Net Cash Provided By Used In Investing Activities | 14551000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Net Cash Provided By Used In Operating Activities | -13365000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20250331 | Operating Expenses | 13337000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20241231 | Property Plant And Equipment Net | 3139000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Research And Development Expense | 16529000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069188 | 20240331 | Restricted Cash Noncurrent | 1600000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Chesapeake Master Lease; | ||
| 0000950170-25-069188 | 20240331 | Revenues | 3500000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Innovent Agreement; | ||
| 0000950170-25-069188 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Innovent Agreement; | ||
| 0000950170-25-069188 | 20250331 | Shares Outstanding | 38339697.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Deferred Revenue Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Income | Amount of revenue and income classified as other. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Restricted Cash Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Increase Decrease In Operating Lease Liabilities | 0000950170-25-069188 | 1 | 0 | monetary | D | D | Increase Decrease In Operating Lease Liabilities | Increase decrease in operating lease liabilities. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Vesting Of Restricted Stock Units | 0000950170-25-069188 | 1 | 0 | shares | D | Vesting Of Restricted Stock Units | Vesting Of restricted stock units | |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Deferred Revenue Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Long Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Long-Term Investments | The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
| Investment Income Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net | Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Restricted Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalents, Current | Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accrued Expenses And Other Current Liabilities | 0000950170-25-069188 | 1 | 0 | monetary | I | C | Accrued Expenses And Other Current Liabilities | Accrued expenses and other current liabilities. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069188 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-069188 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0000950170-25-069188 | 2 | 5 | BS | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-069188 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-069188 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-069188 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-069188 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0000950170-25-069188 | 2 | 10 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash, non-current | 0 |
| 0000950170-25-069188 | 2 | 11 | BS | 0 | H | Long Term Investments | us-gaap/2024 | Long-term investments | 0 |
| 0000950170-25-069188 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-069188 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-069188 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-069188 | 2 | 17 | BS | 0 | H | Accrued Expenses And Other Current Liabilities | 0000950170-25-069188 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-069188 | 2 | 18 | BS | 0 | H | Deferred Revenue Current | us-gaap/2024 | Deferred revenue | 0 |
| 0000950170-25-069188 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities | 0 |
| 0000950170-25-069188 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-069188 | 2 | 21 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0000950170-25-069188 | 2 | 22 | BS | 0 | H | Deferred Revenue Noncurrent | us-gaap/2024 | Deferred revenue, non-current | 0 |
| 0000950170-25-069188 | 2 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0000950170-25-069188 | 2 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-069188 | 2 | 25 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 6) | 0 |
| 0000950170-25-069188 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.00001 par value; 200,000,000 shares authorized at March 31, 2025 and December 31, 2024; 38,339,697 shares issued and outstanding at March 31, 2025 and December 2024, respectively | 0 |
| 0000950170-25-069188 | 2 | 28 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-069188 | 2 | 29 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive gain | 0 |
| 0000950170-25-069188 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-069188 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-069188 | 2 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-069188 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common Stock, Par or Stated Value Per Share | 0 |
| 0000950170-25-069188 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-069188 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares, issued | 0 |
| 0000950170-25-069188 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares, outstanding | 0 |
| 0000950170-25-069188 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Collaboration revenue | 0 |
| 0000950170-25-069188 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-069188 | 4 | 4 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-069188 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-069188 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-069188 | 4 | 8 | IS | 0 | H | Investment Income Net | us-gaap/2024 | Interest income, net | 0 |
| 0000950170-25-069188 | 4 | 9 | IS | 0 | H | Other Income | us-gaap/2024 | Other income | 0 |
| 0000950170-25-069188 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 0 |
| 0000950170-25-069188 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-069188 | 4 | 12 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Net unrealized loss on marketable securities | 0 |
| 0000950170-25-069188 | 4 | 13 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0000950170-25-069188 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0000950170-25-069188 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0000950170-25-069188 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average shares outstanding, basic | 0 |
| 0000950170-25-069188 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average shares outstanding, diluted | 0 |
| 0000950170-25-069188 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-069188 | 5 | 12 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, Shares | 0 |
| 0000950170-25-069188 | 5 | 13 | EQ | 0 | H | Vesting Of Restricted Stock Units | 0000950170-25-069188 | Vesting of restricted stock units | 0 |
| 0000950170-25-069188 | 5 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-069188 | 5 | 15 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on available-for-sale investments | 0 |
| 0000950170-25-069188 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-069188 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-069188 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, Shares | 0 |
| 0000950170-25-069188 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-069188 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0000950170-25-069188 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-069188 | 6 | 6 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of discount on marketable securities | 1 |
| 0000950170-25-069188 | 6 | 7 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Gain on sale of property and equipment | 1 |
| 0000950170-25-069188 | 6 | 8 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Non-cash lease expense | 0 |
| 0000950170-25-069188 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0000950170-25-069188 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0000950170-25-069188 | 6 | 12 | CF | 0 | H | Increase Decrease In Operating Lease Liabilities | 0000950170-25-069188 | Operating lease liabilities | 0 |
| 0000950170-25-069188 | 6 | 13 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue | 0 |
| 0000950170-25-069188 | 6 | 14 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | Other long-term liabilities | 0 |
| 0000950170-25-069188 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-069188 | 6 | 17 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | Proceeds from sales of property and equipment | 0 |
| 0000950170-25-069188 | 6 | 18 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-069188 | 6 | 19 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Maturities of marketable securities | 0 |
| 0000950170-25-069188 | 6 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-069188 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-069188 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | NET INCREASE (DECREASE) IN CASH | 0 |
| 0000950170-25-069188 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of year | 0 |
| 0000950170-25-069188 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0000950170-25-069188 | 6 | 27 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-069188 | 6 | 28 | CF | 0 | H | Restricted Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-069188 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash, cash equivalents and restricted cash | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |